Recent News

Johnson & Johnson Ordered to Pay Woman $417 Million in Talcum Powder Lawsuit

On Monday, August 21st, a Los Angeles jury ordered Johnson & Johnson to pay $417 million in compensatory and punitive damages to a woman suffering from terminal ovarian cancer. The sum is the largest yet awarded to a plaintiff in a series of ongoing talcum powder lawsuits across the United States. The Plaintiff, Mrs. Eva…

Read More...

Monsanto Faced With Lawsuits Over Alleged Connection Between Roundup and Cancer

Roundup is a product known as an herbicide, which is used to destroy weeds and other undesirable vegetation in consumer gardens, industrial farms and other harvestable lands. The product, manufactured by Monsanto, has been on the market since 1974, and is one of the most commonly used of its kind throughout the United States. Glyphosate…

Read More...

FDA: Clinical Trials Show Increased Risk of Amputation with Invokana

Recent safety communications published by the US Food and Drug Administration indicate that type 2 diabetes drug, Invokana (canagliflozin), can cause increased risk for foot and leg amputations. This announcement was made after data from two clinical studies showed that such amputations were necessary in nearly twice as many patients taking Invokana as compared to…

Read More...

Redesigned Olympus Scope Linked to Infection Outbreak

Olympus issued a recall of its TJF-Q180V duodenoscope model in January 2016, after reports linked the device to multiple outbreaks of Carbapenem-resistant enterobacteriaceae (CRE), a form of antibiotic resistant infection that is difficult to treat, and often fatal. Further investigation into the incidents revealed that at least 35 people died after suffering infections linked to…

Read More...

Government Agency Cites Gaps in FDA’s Reporting System In Power Morcellator Report

In August 2015, The Government Accountability Office (GAO) received requests from 12 US Congress Representatives to investigate the FDA’s handling of adverse event reports regarding laparoscopic power morcellator devices. Such reports claimed that the use of laparoscopic power morcellators spread cancer in those being treated for uterine fibroids. Early this year, the GAO released a…

Read More...

FDA Awards Research Grant For Studies Assessing Talc-Ovarian Cancer Risk

Research grants for studies aimed at aiding regulatory decisions and advancing the study of women’s health were awarded by the FDA Office of Women’s Health (OWH). Since 1996, The Office of Women’s Health has funded nine (9) research projects that address medical issues which affect women. The project of the 2016 grant recipient, Nakissa Sadrieh,…

Read More...

Product Recall: What it Means for Consumers

The Law Offices of Peter Angelos is committed to providing information related to defective products, as such products have the potential to cause serious injuries and death to unknowing consumers. There are various agencies, laws and regulations in the United States that govern the dissemination and safety of consumer products. When it is discovered that…

Read More...

Class I Recall: Zimmer Biomet Comprehensive Reverse Shoulder

Zimmer Biomet has issued a Class I recall for its Comprehensive Reverse Shoulder as the devices have exhibited higher rates of fracturing than previously stated. In December 2016, Zimmer Biomet issued an Urgent Medical Device Recall Notice to customers who may have undergone surgery in which a Comprehensive Reverse Shoulder was implanted.  This recall has…

Read More...

Takata Airbag Recall Grows in 2017

Over the past two years, Takata has remained at the center of the largest automobile vehicle recall ever recorded in the United States. This is because the airbags that the manufacturer produces, which are standard in over 45 different models of cars made between 2000 and 2008, were found to be defective and potentially dangerous…

Read More...

FDA Warning: Rare but Serious Allergic Reactions from Skin Antiseptic

On February 2, 2017, the Food and Drug Administration (FDA) issued a warning regarding reports of rare but serious allergic reactions on the skin of individuals who have used over-the-counter (OTC) products containing chlorhexidine gluconate. The FDA has requested that manufacturers, which produce antiseptic containing the ingredient, issue a warning detailing the risk on the…

Read More...